hit counter
Acorda Therapeutics, Inc. (ACOR) Stock News Sentiment & Price - Sentifly
ACOR - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Acorda Therapeutics, Inc. (ACOR)

USA
Biotechnology
NASDAQ
ACOR Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ACOR Latest news
Seeking Alpha
Neutral
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2021 Results - Earnings Call Transcript
2021-11-09 22:09

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2021 Results - Earnings Call Transcript

Business Wire
Neutral
Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team
2021-11-09 16:01

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team

Business Wire
Neutral
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany
2021-11-09 16:01

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany

Benzinga
Neutral
Earnings Outlook For Acorda Therapeutics
2021-11-08 09:57

Acorda Therapeutics (NASDAQ:ACOR) is set to give its latest quarterly earnings report on Tuesday, 2021-11-09. Here's what investors need to know before the announcement.

Business Wire
Neutral
Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
2021-11-02 07:00

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021

Business Wire
Neutral
Acorda Therapeutics Announces Corporate Restructuring, Management Changes
2021-09-09 08:01

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics Announces Corporate Restructuring, Management Changes

Seeking Alpha
Neutral
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2021 Results - Earnings Call Transcript
2021-08-08 10:50

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
Acorda Therapeutics (ACOR) Reports Q2 Loss, Tops Revenue Estimates
2021-08-05 19:01

Acorda (ACOR) delivered earnings and revenue surprises of -9.57% and 6.16%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Business Wire
Neutral
Acorda Therapeutics Reports Second Quarter 2021 Financial Results
2021-08-05 16:01

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics Reports Second Quarter 2021 Financial Results

Business Wire
Neutral
Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021
2021-07-30 16:01

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021

Loading more news...